Evidence map›Paper›PMID 38852281›Full record

ArticleBiochemical and biophysical research communications2024

Exploring the role of casein kinase 1α splice variants across cancer cell lines.

Ricardo A Meléndez, Daniel T Wynn, Siva Bharath Merugu, Prerna Singh, Kenton P Kaplan, David J Robbins

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ricardo A MeléndezDepartment of Biochemistry and Molecular Biology University of Miami Miller School of Medicine Miami FL, USA; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA.
Daniel T WynnDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA.
Siva Bharath MeruguDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA.
Prerna SinghDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA.
Kenton P KaplanDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA.
David J RobbinsDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, D.C, USA. Electronic address: dr956@georgetown.edu.

Funding

Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI STEPHEN W BYERS · 1990 to 2026
$71.5M
TRAINING GRANT IN TUMOR BIOLOGYT32CA009686 · NCI · GEORGETOWN UNIVERSITY · PI ANNA Tate RIEGEL, DAVID J ROBBINS · 1996 to 2026
$10.8M
Targeting Wnt-dependent colorectal cancerR01CA219189 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI ROBBINS, DAVID J · 2018 to 2022
$1.9M
Pharmacological Sciences Training Program (PSTP)T32GM142520 · NIGMS · GEORGETOWN UNIVERSITY · PI Patrick Alexander Forcelli, Anton Wellstein · 2022 to 2026
$1.3M
NCI NIH HHS P30 CA051008NCI NIH HHS R01 CA219189NCI NIH HHS T32 CA009686NIGMS NIH HHS T32 GM142520
6 · The paper itself

Abstract

Casein kinase 1α (CK1α) is a serine/threonine protein kinase that acts in various cellular processes affecting cell division and signal transduction. CK1α is present as multiple splice variants that are distinguished by the presence or absence of a long insert (L-insert) and a short carboxyl-terminal insert (S-insert). When overexpressed, zebrafish CK1α splice variants exhibit different biological properties, such as subcellular localization and catalytic activity. However, whether endogenous, alternatively spliced CK1α gene products also differ in their biological functions has yet to be elucidated. Here, we identify a panel of splice variant specific CK1α antibodies and use them to show that four CK1α splice variants are expressed in mammals. We subsequently show that the relative abundance of CK1α splice variants varies across distinct mouse tissues and between various cancer cell lines. Furthermore, we identify pathways whose expression is noticeably altered in cell lines enriched with select splice variants of CK1α. Finally, we show that the S-insert of CK1α promotes the growth of HCT 116 cells as cells engineered to lack the S-insert display decreased cell growth. Together, we provide tools and methods to identify individual CK1α splice variants, which we use to begin to uncover the differential biological properties driven by specific splice variants of mammalian CK1α.

Indexed as

Alternative SplicingCasein Kinase IalphaAnimalsCell Line, TumorCell ProliferationHCT116 CellsHumansIsoenzymesMiceNeoplasmsCasein Kinase IalphaCsnk1a1 protein, mouseIsoenzymesCancerCasein kinase 1αSplice variants

Identifiers

PMID38852281
PMCPMC11287285

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.